Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
EMBC Embecta
27.400+0.520+1.93%
Close
01/27 16:00 ET
27.250-0.150-0.55%
Post Mkt Price 01/27 19:28 ET
High
27.640
Open
26.830
Turnover
21.74M
Low
26.380
Pre Close
26.880
Volume
797.42K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Oregon Public Employees Retirement Fund Purchases Shares of 19,083 Embecta Corp. (NASDAQ:EMBC)
Oregon Public Employees Retirement Fund purchased a new stake in shares of Embecta Corp. (NASDAQ:EMBC – Get Rating) during the third quarter, according to the company in its most recent disclosure w
Royce & Associates LP Invests $615,000 in Embecta Corp. (NASDAQ:EMBC)
Royce & Associates LP acquired a new position in shares of Embecta Corp. (NASDAQ:EMBC – Get Rating) in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional invest
Raymond James Financial Services Advisors Inc. Buys Shares of 16,933 Embecta Corp. (NASDAQ:EMBC)
Raymond James Financial Services Advisors Inc. bought a new stake in shares of Embecta Corp. (NASDAQ:EMBC – Get Rating) in the third quarter, according to the company in its most recent disclosure w
Campbell Appoints Carrie Anderson Chief Financial Officer
Campbell Soup Company (NYSE:CPB) today announced the appointment of Carrie L. Anderson as Executive Vice President and Chief Financial Officer, effective Feb. 6. This press release features multimedia. View the full
Embecta Opens New Global Headquarters in Parsippany, N.J.
PARSIPPANY, N.J., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world following its April 1, 2022, spinoff f
Embecta Corp. (NASDAQ:EMBC) Short Interest Update
Embecta Corp. (NASDAQ:EMBC – Get Rating) saw a large decrease in short interest in December. As of December 30th, there was short interest totalling 3,900,000 shares, a decrease of 5.8% from the Dec
Embecta to Report Fiscal First Quarter 2023 Financial Results
PARSIPPANY, N.J., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, will host a conference call to discus
Embecta Corp. (NASDAQ:EMBC) Sees Large Drop in Short Interest
Embecta Corp. (NASDAQ:EMBC – Get Rating) saw a significant drop in short interest in the month of December. As of December 30th, there was short interest totalling 3,900,000 shares, a drop of 5.8% f
State of New Jersey Common Pension Fund D Takes Position in Embecta Corp. (NASDAQ:EMBC)
State of New Jersey Common Pension Fund D purchased a new stake in shares of Embecta Corp. (NASDAQ:EMBC – Get Rating) during the 3rd quarter, according to the company in its most recent disclosure w
Kinneret Advisory LLC Takes $43,000 Position in Embecta Corp. (NASDAQ:EMBC)
Kinneret Advisory LLC bought a new stake in Embecta Corp. (NASDAQ:EMBC – Get Rating) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institut
Company Overview
More
Embecta Corp. engages in manufacturing and distributing medical devices used in the treatment of diabetes. It delivers insulin for diabetic patients to improve their lives. The company is headquartered in Parsippany, NJ.
CEO： Mr. Devdatt Kurdikar
Market： NASDAQ
Listing Date： 03/22/2022
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet